Who owns PLUS THERAPEUTICS INC?
- CUSIP Number: 72941h509
Tip: Access positions for across all investors
Analyze quarterly positions in Plus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Plus Therapeutics stock
Who bought or sold PLUS THERAPEUTICS INC this quarter?
There are no current stakeholders of Plus Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Plus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Capital Management | Mar 2026 | 2.4M | $396k |
| Geode Capital Management | Mar 2026 | 2.0M | $328k |
| BlackRock | Mar 2026 | 1.8M | $289k |
| Vanguard Fiduciary Trust | Mar 2026 | 1.2M | $190k |
| State Street Corporation | Mar 2026 | 469k | $76k |
| Northern Trust | Mar 2026 | 293k | $48k |
| Millennium Management | Mar 2026 | 272k | $44k |
| Two Sigma Securities | Mar 2026 | 143k | $23k |
| XTX Topco | Mar 2026 | 116k | $19k |